400 related articles for article (PubMed ID: 29908086)
21. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
[TBL] [Abstract][Full Text] [Related]
22. Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
Berti A; Volcheck GW; Cornec D; Smyth RJ; Specks U; Keogh KA
Respir Med; 2018 Sep; 142():66-72. PubMed ID: 30170804
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil extracellular traps formation in patients with eosinophilic granulomatosis with polyangiitis: association with eosinophilic inflammation.
Natorska J; Ząbczyk M; Siudut J; Krawiec P; Mastalerz L; Undas A
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):27-32. PubMed ID: 28229830
[TBL] [Abstract][Full Text] [Related]
24. [Neurological disorders in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
Gilyarov MY; Belikova LP; Shchukin IA; Fidler MS; Avakyan GG; Shustrova GE; Martynov MY; Svet AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):93-102. PubMed ID: 28635862
[TBL] [Abstract][Full Text] [Related]
25. An increase of CD83+ dendritic cells ex vivo correlates with increased regulatory T cells in patients with active eosinophilic granulomatosis and polyangiitis.
Tsurikisawa N; Saito H; Oshikata C; Tsuburai T; Ishiyama M; Mitomi H; Akiyama K
BMC Immunol; 2014 Aug; 15():32. PubMed ID: 25174446
[TBL] [Abstract][Full Text] [Related]
26. Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis.
Hashimoto T; Ueki S; Kamide Y; Miyabe Y; Fukuchi M; Yokoyama Y; Furukawa T; Azuma N; Oka N; Takeuchi H; Kanno K; Ishida-Yamamoto A; Taniguchi M; Hashiramoto A; Matsui K
Front Immunol; 2021; 12():801897. PubMed ID: 35095884
[TBL] [Abstract][Full Text] [Related]
27. Presence of purpura is related to active inflammation in association with IL-5 in eosinophilic granulomatosis with polyangiitis.
Kataoka H; Tomita T; Kondo M; Mukai M
Rheumatol Int; 2021 Feb; 41(2):449-454. PubMed ID: 32770271
[TBL] [Abstract][Full Text] [Related]
28. Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Cottin V; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME; Groh M; Marchand-Adam S; Khouatra C; Wallaert B; Taillé C; Delaval P; Cadranel J; Bonniaud P; Prévot G; Hirschi S; Gondouin A; Dunogué B; Chatté G; Briault A; Jayne D; Guillevin L; Cordier JF;
Eur Respir J; 2016 Nov; 48(5):1429-1441. PubMed ID: 27587545
[TBL] [Abstract][Full Text] [Related]
29. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
[TBL] [Abstract][Full Text] [Related]
30. Severe Asthma Where Eosinophilic Granulomatosis with Polyangiitis Became Apparent after the Discontinuation of Dupilumab.
Ikeda M; Ohshima N; Kawashima M; Shiina M; Kitani M; Suzukawa M
Intern Med; 2022 Mar; 61(5):755-759. PubMed ID: 34393172
[TBL] [Abstract][Full Text] [Related]
31. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Cottin V; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME; Groh M; Marchand-Adam S; Khouatra C; Wallaert B; Taillé C; Delaval P; Cadranel J; Bonniaud P; Prévot G; Hirschi S; Gondouin A; Dunogué B; Chatté G; Briault C; Pagnoux C; Jayne D; Guillevin L; Cordier JF;
Autoimmun Rev; 2017 Jan; 16(1):1-9. PubMed ID: 27671089
[TBL] [Abstract][Full Text] [Related]
32. An Atypical Case of Non-asthmatic Eosinophilic Granulomatosis with Polyangiitis Finally Diagnosed by Tissue Biopsy.
Kobayashi T; Kanno K; Kikuchi Y; Kakimoto M; Kawahara A; Kimura K; Ishida R; Miyamori D; Otani Y; Kishikawa N; Tazuma S
Intern Med; 2019 Mar; 58(6):871-875. PubMed ID: 30449779
[TBL] [Abstract][Full Text] [Related]
33. Eosinophilic granulomatosis with polyangitis: A new target for biologicals.
Bayrak Durmaz MS; Çelebi Sözener Z; Bavbek S
Tuberk Toraks; 2022 Mar; 70(1):93-101. PubMed ID: 35362309
[TBL] [Abstract][Full Text] [Related]
34. Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab.
Tsurikisawa N; Oshikata C; Watanabe M; Fukuda N; Yamaguchi T; Kiyohara H; Kaneko T
Int Arch Allergy Immunol; 2021; 182(8):744-756. PubMed ID: 33887721
[TBL] [Abstract][Full Text] [Related]
35. [Benralizumab in cases of eosinophilic granulomatosis with polyangiitis].
Carrette A; Mercier V; Lelubre C; Peché R
Rev Mal Respir; 2022 Sep; 39(7):621-625. PubMed ID: 35909008
[TBL] [Abstract][Full Text] [Related]
36. [Anti-IL-5 in severe asthma associated with eosinophilic granulomatosis with polyangiitis. Real-life study].
Akdime F; Habib S; Regard L; Terrier B; Cohen P; Mouthon L; Guillevin L; Burgel PR; Honore I; Puéchal X; Roche N
Rev Mal Respir; 2023; 40(9-10):732-742. PubMed ID: 37923651
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Eosinophilic Granulomatosis With Polyangiitis and Associated Health Care Utilization Among Patients With Concomitant Asthma in US Commercial Claims Database.
Gokhale M; Bell CF; Doyle S; Fairburn-Beech J; Steinfeld J; Van Dyke MK
J Clin Rheumatol; 2021 Apr; 27(3):107-113. PubMed ID: 31693654
[TBL] [Abstract][Full Text] [Related]
38. Serum Proteomic Analysis Identifies SAA1, FGA, SAP, and CETP as New Biomarkers for Eosinophilic Granulomatosis With Polyangiitis.
Xiao J; Lu S; Wang X; Liang M; Dong C; Zhang X; Qiu M; Ou C; Zeng X; Lan Y; Hu L; Tan L; Peng T; Zhang Q; Long F
Front Immunol; 2022; 13():866035. PubMed ID: 35757752
[TBL] [Abstract][Full Text] [Related]
39. The Role of T Helper Type 2 (Th2) Cytokines in the Pathogenesis of Eosinophilic Granulomatosis with Polyangiitis (eGPA): an Illustrative Case and Discussion.
Milne ME; Kimball J; Tarrant TK; Al-Rohil RN; Leverenz DL
Curr Allergy Asthma Rep; 2022 Nov; 22(11):141-150. PubMed ID: 36103081
[TBL] [Abstract][Full Text] [Related]
40. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
